JSPR

Conviction 18HealthcareScan · Mon, Aug 10, 2026

JSPR$0.7947+12.01%

ResistanceSupportVol 14Insider buy

Vol MA14 529.64K

May 11May 28Jun 16Jul 6Jul 23Aug 10

Jasper Therapeutics, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.jaspertherapeutics.com ↗

Price0.7947

Change+12.01%

Gap+3.33%

Rel volume0.02×

Avg volume3.12M

Avg $ vol2.54M

SMA 200.7040

SMA 500.5780

SMA 2001.20

Price vs 50+37.49%

Price vs 200-34.01%

MA stackmixed

50/200 cross—

Supertrendup · 0.4888

RSI (14)63

MACD hist0.00

MACD crossbull · 0d

Stoch %K / %D94 / 57

ADX (14)30

+DI / −DI26 / 11

RSI divergence—

MACD divergence—

ATR %+12.01%

ADR %14.87%

52w high3.11

52w low0.3410

From 52w high-74.45%

Above 52w low+133.05%

New 52w highNo

SqueezeOff

Bollinger width42.15%

%B0.81

Donchian pos50.96%

Donchian high1.03

Donchian low0.5502

AVWAP (52w high)1.37

vs AVWAP high-41.90%

AVWAP (52w low)0.7567

vs AVWAP low+5.02%

OBV trendUp

Chaikin MF (20)0.32

Today vs 20d0.02×

Avg vol (14d)529.64K

Avg vol (20d)3.12M

Avg $ vol (20d)2.54M

Market cap22.25M

RS 3m (vs SPY)-27.59%

RS 6m (vs SPY)-58.25%

RS line new highNo

Trend template2/8

Technical rank41.9

1 week+31.07%

1 month+37.14%

3 months-14.21%

6 months-41.13%

1 year-70.89%

YTD-56.81%

P/E-0.29

P/B6.54

P/S—

P/FCF—

EPS-3.95

Div yield—

ROE—

ROA-357.82%

Debt/Eq—

Current2.26

EV/EBITDA-0.10

Gross margin—

Net margin—

Rev growth—

EPS growth-6.36%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value8.11M

Revenue—

Net income-1.17M

Gross profit—

Free cash flow—

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out28M

Employees22

ListedMon, Sep 27, 2021

Free float22.74M

Float %81.2%

Short interest1.66M

Days to cover1.9d

Short volume52.6%

Squeeze score32 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction18 / 100

Pattern quality—

Tech rank41.9 / 100

Group rank—

Status laneNo active setup

Setup direction—

Pattern family

Resistance0.8150

Support0.3730

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in JSPR

All disclosures →

No recent disclosed trades by Congress in JSPR. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in JSPR · 1 buy

Insider	Side	Shares	Value	Traded	Filed
Ros Matthew E Chief Operating Officer · Non-Voting Convertible Preferred Stock · 2026-07-20	Buy	881	—	2026-07-20	2026-07-22

SEC filings

EDGAR filings in JSPR · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.